The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients

Warning

This publication doesn't include Faculty of Sports Studies. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	DOUBEK Michael MALČÍKOVÁ Jitka BRYCHTOVÁ Yvona PANOVSKÁ Anna KOZMON Petr DOBEŠ Petr VAŇKOVÁ Gabriela ŠMARDOVÁ Jana KUGLÍK Petr MRÁZ Marek TICHÝ Boris ŠEBEJOVÁ Ludmila MAYER Jiří TRBUŠEK Martin POSPÍŠILOVÁ Šárka
Year of publication	2011
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies Real-time PCR soupravy pro diagnostiku v onkologii Funkční a strukturní změny microRNA u lymfoproliferativních malignit a jejich vliv na prognózu onemocnění a predikci léčebné odpovědi